Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial - Aix-Marseille Université Access content directly
Journal Articles International Journal of Antimicrobial Agents Year : 2020

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Stéphane Honoré
Fichier principal
Vignette du fichier
S0924857920300996.pdf (387.19 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-02525126 , version 1 (22-08-2022)

Licence

Attribution - NonCommercial

Identifiers

Cite

Philippe Gautret, Jean-Christophe J.-C. Lagier, Philippe Parola, van Thuan Hoang, Line Meddeb, et al.. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents, 2020, pp.105949. ⟨10.1016/j.ijantimicag.2020.105949⟩. ⟨hal-02525126⟩
223 View
55 Download

Altmetric

Share

Gmail Facebook X LinkedIn More